Patients who have other primary cancers have increased risk for renal cancer, the authors of a retrospective study reported yesterday. But while physicians should be alert to the possibility of renal cancer, the risk is not high enough to warrant that all patients in this population should be screened, the authors advise.
Patients who have other primary cancers have increased risk for renal cancer, the authors of a retrospective study reported yesterday. But while physicians should be alert to the possibility of renal cancer, the risk is not high enough to warrant that all patients in this population should be screened, the authors advise.
Lead author Joel W. Slaton, MD, assistant professor of urology, University of Minnesota, reviewed a cancer database of 1.3 million patients diagnosed between 1973 and 1993. He found that patients who have a prior cancer are two to five times more likely to be identified with a renal tumor. A patient's risk of developing another tumor of some other origin is about 9%. The chance that it will be a renal cancer is 0.06%.
According to Dr. Slaton, patients with prostate or lung cancer had the highest risk for being identified with kidney cancer (3.5- to 4.5-fold, respectively). That is compared with a 2.5-fold increased risk of patients with head and neck cancer. Further, men with lung and colon cancer were more likely (3.9- and 4.5-fold, respectively) than women (2.6- and 1.9-fold, respectively) to develop renal cancer after primary cancer.
Dr. Chan on prevention, diagnosis, and treatment of kidney stones in pediatric patients
July 26th 2024"Stones that recur in children happen about 40% to 50% of the time. That's why the American Urological Association guidelines recommend doing a complete metabolic evaluation in all children," says Katherine Chan, MD, MPH.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.